Cite
US and EU radiopharmaceutical diagnostic and therapeutic nonclinical study requirements for clinical trials authorizations and marketing authorizations.
MLA
Schwarz, Sally W., and Clemens Decristoforo. “US and EU Radiopharmaceutical Diagnostic and Therapeutic Nonclinical Study Requirements for Clinical Trials Authorizations and Marketing Authorizations.” EJNMMI Radiopharmacy & Chemistry, vol. 4, no. 1, May 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s41181-019-0059-2.
APA
Schwarz, S. W., & Decristoforo, C. (2019). US and EU radiopharmaceutical diagnostic and therapeutic nonclinical study requirements for clinical trials authorizations and marketing authorizations. EJNMMI Radiopharmacy & Chemistry, 4(1), N.PAG. https://doi.org/10.1186/s41181-019-0059-2
Chicago
Schwarz, Sally W., and Clemens Decristoforo. 2019. “US and EU Radiopharmaceutical Diagnostic and Therapeutic Nonclinical Study Requirements for Clinical Trials Authorizations and Marketing Authorizations.” EJNMMI Radiopharmacy & Chemistry 4 (1): N.PAG. doi:10.1186/s41181-019-0059-2.